Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Advanced
New in RUL
About RUL
In numbers
Help
Sign in
Details
Synthesis of a fac-tricarbonylrhenium(I) complex with pyrithione, its physicochemical characterization, and assessment of biological effects
ID
Rapuš, Uroš
(
Author
),
ID
Pivarcsik, Tamás
(
Author
),
ID
Mitrović, Ana
(
Author
),
ID
Kljun, Jakob
(
Author
),
ID
Bogdanov, Anita
(
Author
),
ID
Spengler, Gabriella
(
Author
),
ID
Meden, Anže
(
Author
),
ID
Gobec, Stanislav
(
Author
),
ID
Kos, Janko
(
Author
),
ID
Enyedy, Éva Anna
(
Author
),
ID
Turel, Iztok
(
Author
)
PDF - Presentation file,
Download
(8,34 MB)
MD5: D1206CD777D87FEA2792F266DA95E1F8
URL - Source URL, Visit
https://pubs.acs.org/doi/10.1021/acsomega.5c06647
Image galllery
Abstract
Research on rhenium complexes containing fac-tricarbonyl fragments has been on the rise in recent decades. Some complexes of this type exhibit advantageous properties that can be utilized in diagnostic and therapeutic applications. Herein, we report on the synthesis, structural characterization, solution speciation, and biological activity with mode of action studies of a new fac-tricarbonylrhenium(I) complex with pyrithione ligand fac-[Re(CO)$_3$(pyrithionato)(benzonitrile)] (4). In an attempt to prepare a stable rhenium(I) complex with a pyrithionato ligand, several synthesis procedures were investigated and various products were discovered. In solution, the monodentate benzonitrile ligand can be replaced by a coordinating solvent molecule; however, the carbonyl ligands and pyrithione remain bound to the rhenium center. Complex 4 exhibited strong cytotoxic and antibacterial activity and effectively inhibited the growth of the HSV-2 virus. Additionally, complex 4 was also able to inhibit the cathepsin B enzyme (both its endo- and exopeptidase activities). In silico experiments confirmed that complex 4 can interact with cathepsin B near its active site, which may contribute to reduced enzymatic activity.
Language:
English
Keywords:
antimicrobial agents
,
degradation
,
inhibition
,
ligands
,
peptides
,
proteins
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FKKT - Faculty of Chemistry and Chemical Technology
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Year:
2025
Number of pages:
Str. 38272-38291
Numbering:
Vol. 10, iss. 33
PID:
20.500.12556/RUL-172601
UDC:
546.719:547.82
ISSN on article:
2470-1343
DOI:
10.1021/acsomega.5c06647
COBISS.SI-ID:
247217923
Publication date in RUL:
09.09.2025
Views:
465
Downloads:
295
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
ACS omega
Shortened title:
ACS omega
Publisher:
American Chemical Society
ISSN:
2470-1343
COBISS.SI-ID:
525873945
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Secondary language
Language:
Slovenian
Keywords:
renij
,
trikarbonilrenijevi(I) kompleksi
,
pirition
,
biološka aktivnost
Projects
Funder:
ARIS - Slovenian Research and Innovation Agency
Funding programme:
Young researchers
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P1-0175
Name:
Napredna anorganska kemija
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P4-0127
Name:
Farmacevtska biotehnologija: znanost za zdravje
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
J3-3071
Name:
Katepsina B in X v tumorskih matičnih celicah raka dojke – molekulske tarče in pomen za protitumorno terapijo
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
P1-0208
Name:
Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin
Funder:
ARIS - Slovenian Research and Innovation Agency
Project number:
I0-0022
Name:
Mreža raziskovalnih infrastrukturnih centrov Univerze v Ljubljani (MRIC UL)
Funder:
COST - European Cooperation in Science and Technology
Project number:
CA21145
Acronym:
EURESTOP
Funder:
Hungarian Academy of Sciences
Funder:
Slovenian Academy of Sciences and Arts
Funder:
Hungary, Ministry of Culture and Innovation, National Research, Development and Innovation Fund
Funding programme:
TKP2021-EGA
Project number:
TKP2021-EGA-32
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back